Haloperidol, midazolam and intravenous sedation.
Ryan
C J
CJ
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016292:Procedural Sedation; D004305:Dose-Response Relationship, Drug; D004637:Emergency Services, Psychiatric; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D008874:Midazolam / Q000008:administration & dosage / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000188:drug therapy*; D012307:Risk Factors; D016171:Torsades de Pointes / Q000139:chemically induced*
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D006220:Haloperidol; D008874:Midazolam